SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-16-006253
Filing Date
2016-06-02
Accepted
2016-06-02 16:17:12
Documents
3
Period of Report
2016-05-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acrs-20160527x8k.htm 8-K 41675
2 EX-10.1 acrs-20160527ex101760862.htm EX-10.1 361128
3 EX-10.2 acrs-20160527ex1027ee887.htm EX-10.2 158719
  Complete submission text file 0001558370-16-006253.txt   562692
Mailing Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355
Business Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355 484-321-5554
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37581 | Film No.: 161692661
SIC: 2834 Pharmaceutical Preparations